Cel-Sci Corporation

CVM Healthcare Biotechnology

In the quarter to June 2026, EPS grew 65.4%, free cash flow fell 2.33% and total debt fell 39.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

1.79 0.05 +2.87%
Market cap
$30.6M
P/E
0.0×
Fwd P/E
−12.2×
Dividend yield
—
F-score
4/9
Altman Z
−1.64
Beneish M
−2.35
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Sep '16 Sep '17 Sep '18 Sep '19 Sep '20 Sep '21 Sep '22 Sep '23 Sep '24 Sep '25
Total current assets
5.46 4.24 11.44 9.81 17.70 45.27 25.44 6.92 6.06 11.60
Total non-current assets
19.43 18.69 18.15 17.81 22.84 30.60 25.09 23.61 20.94 16.56
Total Assets
24.89 22.92 29.59 27.62 40.54 75.87 50.52 30.53 26.99 28.16
Total current liabilities
4.01 10.84 9.23 3.02 4.27 3.94 4.66 5.59 4.62 5.13
Total non-current liabilities
21.55 15.42 20.36 19.47 16.54 15.40 13.70 11.73 9.51 7.07
Total liabilities
25.57 26.26 29.59 22.49 20.81 19.34 18.36 17.31 14.12 12.20
Common Equity (Total)
(0.68) (3.34) 0.00 5.13 19.73 56.53 32.16 13.21 12.87 15.96
Shareholders Equity (Total)
(0.68) (3.34) 0.00 5.13 19.73 56.53 32.16 13.21 12.87 15.96
Total Debt
13.01 13.21 13.38 13.51 11.75 13.25 11.72 9.95 7.96 5.68

Show all line items

In millions of $ except per-share values · columns are period end dates